Analysis of 3789 in- and outpatient XXXX isolates from across Canada--results of the CANWARD 2007-2009 study.

@entity801 @entity2756 @entity7048 @entity6616 @entity5505 @entity799 @entity115 @entity2177 @entity7120 @entity798 @entity2887 @entity3398 @entity3400 @entity800 @entity9001 @entity526
@entity526 was the most commonly isolated pathogen in the Canadian Ward Surveillance Study 2007-2009 (3789 isolates). Susceptibility to @entity7048 (34.1%), @entity799 (73.8%), @entity2177 (78.4%), and @entity800 (78.8%) was lowest. Susceptibility was above 90% for meropenem (100%), @entity9001 (99.9%), @entity3400 - @entity7120 (97.6%), @entity6616 (96.9%), @entity5505 (95.6%), @entity115 - @entity798 (94.9%), @entity2756 (94.1%), @entity3398 (92.3%), and @entity801 (90.8%). Over the study period, there was a significant reduction in susceptibility to @entity115 - @entity798 and @entity799 for urinary tract isolates. Inpatient status was associated with greater resistance to nearly all antimicrobials including greater multidrug resistance (MDR). Increasing age was associated with resistance to @entity2887 , @entity2756 , @entity3400 - @entity7120 , and MDR. Female gender was associated with susceptibility to @entity2887 and @entity6616 . In conclusion, greater antimicrobial resistance and MDR in @entity526 were observed in inpatients, males, and with increasing age. The deterioration of susceptibility to @entity799 continues with the greatest reduction in urinary isolates. Significant regional differences in resistance rates were apparent.
